Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathilde Jalving

Showing results (11-20 of 78) with videos related to

Pageof 8
Sort By:
Melanoma Management|November 22, 2018
Preoperative <i>BRAF</i> inhibition in patients with irresectable locally advanced stage III melanomaMarloes Faut, Mathilde Jalving, Gilles F Diercks, et al.
Gynecologic Oncology|June 1, 2022
End-of-life care for patients with advanced ovarian cancer in the Netherlands: A retrospective registry-based analysisK Esther Broekman, Maaike A van der Aa, Hans W Nijman, et al.
BMC Cancer|March 6, 2022
Anti-tumor treatment and healthcare consumption near death in the era of novel treatment options for patients with melanoma brain metastasesAnnemarie C Eggen, Geke A P Hospers, Ingeborg Bosma, et al.
Medicine|November 16, 2018
A methodology to systematically analyze the hospital discharge of terminally ill patientsAnnemarie Cécile Eggen, Mathilde Jalving, Ingeborg Bosma, et al.
Cancers|October 13, 2021
Type 2 Diabetes Mellitus and Clinicopathological Tumor Characteristics in Women Diagnosed with Breast Cancer: A Systematic Review and Meta-AnalysisFan Zhang, Jing de Haan-Du, Grigory Sidorenkov, et al.
Critical Reviews in Oncology/Hematology|October 18, 2022
Towards less mutilating treatments in patients with advanced non-melanoma skin cancers by earlier use of immune checkpoint inhibitorsJahlisa S Hooiveld-Noeken, Annemarie C Eggen, Emõke Rácz, et al.
Cancer Treatment Reviews|May 15, 2022
The gut wall's potential as a partner for precision oncology in immune checkpoint treatmentSara Hone Lopez, Mathilde Jalving, Rudolf S N Fehrmann, et al.
Melanoma Research|January 29, 2020
Gut microbial species and metabolic pathways associated with response to treatment with immune checkpoint inhibitors in metastatic melanomaThijs T Wind, Ranko Gacesa, Arnau Vich Vila, et al.
Gynecologic Oncology|April 3, 2019
Determinants of health-related quality of life in elderly ovarian cancer patients: The role of frailty and dependenceFernanda Nunes de Arruda, Maaike H M Oonk, Marian J E Mourits, et al.
Analytical Chemistry|June 1, 2021
Simultaneous Quantification of the Concentration and Carbon Isotopologue Distribution of Polar Metabolites in a Single Analysis by Gas Chromatography and Mass SpectrometryBernard Evers, Albert Gerding, Theo Boer, et al.
Pageof 8

Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
Melanoma Management|November 22, 2018
Preoperative <i>BRAF</i> inhibition in patients with irresectable locally advanced stage III melanomaMarloes Faut, Mathilde Jalving, Gilles F Diercks, et al.
Gynecologic Oncology|June 1, 2022
End-of-life care for patients with advanced ovarian cancer in the Netherlands: A retrospective registry-based analysisK Esther Broekman, Maaike A van der Aa, Hans W Nijman, et al.
BMC Cancer|March 6, 2022
Anti-tumor treatment and healthcare consumption near death in the era of novel treatment options for patients with melanoma brain metastasesAnnemarie C Eggen, Geke A P Hospers, Ingeborg Bosma, et al.
Medicine|November 16, 2018
A methodology to systematically analyze the hospital discharge of terminally ill patientsAnnemarie Cécile Eggen, Mathilde Jalving, Ingeborg Bosma, et al.
Cancers|October 13, 2021
Type 2 Diabetes Mellitus and Clinicopathological Tumor Characteristics in Women Diagnosed with Breast Cancer: A Systematic Review and Meta-AnalysisFan Zhang, Jing de Haan-Du, Grigory Sidorenkov, et al.
Critical Reviews in Oncology/Hematology|October 18, 2022
Towards less mutilating treatments in patients with advanced non-melanoma skin cancers by earlier use of immune checkpoint inhibitorsJahlisa S Hooiveld-Noeken, Annemarie C Eggen, Emõke Rácz, et al.
Cancer Treatment Reviews|May 15, 2022
The gut wall's potential as a partner for precision oncology in immune checkpoint treatmentSara Hone Lopez, Mathilde Jalving, Rudolf S N Fehrmann, et al.
Melanoma Research|January 29, 2020
Gut microbial species and metabolic pathways associated with response to treatment with immune checkpoint inhibitors in metastatic melanomaThijs T Wind, Ranko Gacesa, Arnau Vich Vila, et al.
Gynecologic Oncology|April 3, 2019
Determinants of health-related quality of life in elderly ovarian cancer patients: The role of frailty and dependenceFernanda Nunes de Arruda, Maaike H M Oonk, Marian J E Mourits, et al.
Analytical Chemistry|June 1, 2021
Simultaneous Quantification of the Concentration and Carbon Isotopologue Distribution of Polar Metabolites in a Single Analysis by Gas Chromatography and Mass SpectrometryBernard Evers, Albert Gerding, Theo Boer, et al.
Pageof 8